These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
750 related items for PubMed ID: 22921685
1. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E. J Immunol Methods; 2012 Nov 30; 385(1-2):60-70. PubMed ID: 22921685 [Abstract] [Full Text] [Related]
2. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Kis LL, Takahara M, Nagy N, Klein G, Klein E. Immunol Lett; 2006 Apr 15; 104(1-2):83-8. PubMed ID: 16386314 [Abstract] [Full Text] [Related]
3. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. J Med Virol; 2001 Sep 15; 65(1):114-20. PubMed ID: 11505452 [Abstract] [Full Text] [Related]
4. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Ohshima K, Suzumiya J, Tasiro K, Mukai Y, Tanaka T, Kato A, Kikuchi M. Am J Hematol; 1996 May 15; 52(1):21-8. PubMed ID: 8638607 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G. Am J Pathol; 1993 Oct 15; 143(4):1072-85. PubMed ID: 8214003 [Abstract] [Full Text] [Related]
6. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2. Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E. Int J Cancer; 2005 Mar 01; 113(6):937-45. PubMed ID: 15514968 [Abstract] [Full Text] [Related]
7. T cell recognition of Epstein-Barr virus associated lymphomas. Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Cancer Surv; 1992 Mar 01; 13():53-80. PubMed ID: 1330300 [Abstract] [Full Text] [Related]
8. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma. Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E. Blood; 2011 Jan 06; 117(1):165-74. PubMed ID: 20876453 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. J Pathol; 1997 Jun 06; 182(2):151-9. PubMed ID: 9274524 [Abstract] [Full Text] [Related]
10. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter. Kis LL, Salamon D, Persson EK, Nagy N, Scheeren FA, Spits H, Klein G, Klein E. Proc Natl Acad Sci U S A; 2010 Jan 12; 107(2):872-7. PubMed ID: 20080768 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ, Crawford DH, Thomas JA. J Gen Virol; 1993 Mar 12; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [Abstract] [Full Text] [Related]
12. [Studies on transforming functions of Epstein-Barr virus-specific proteins]. Kinoshita T. Hokkaido Igaku Zasshi; 1990 Jul 12; 65(4):362-75. PubMed ID: 2172130 [Abstract] [Full Text] [Related]
13. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Kis LL, Takahara M, Nagy N, Klein G, Klein E. Blood; 2006 Apr 01; 107(7):2928-35. PubMed ID: 16332968 [Abstract] [Full Text] [Related]
14. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. J Cell Physiol; 1993 Mar 01; 154(3):486-95. PubMed ID: 8382208 [Abstract] [Full Text] [Related]
15. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40. Crawford DH, Thomas JA, Gregory CD, Catovsky D, Chaggar K. Leukemia; 1995 May 01; 9(5):747-53. PubMed ID: 7539512 [Abstract] [Full Text] [Related]
16. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Klein G, Klein E, Kashuba E. Biochem Biophys Res Commun; 2010 May 21; 396(1):67-73. PubMed ID: 20494113 [Abstract] [Full Text] [Related]
17. Infection of leukaemic B lymphocytes by Epstein Barr virus. Doyle MG, Catovsky D, Crawford DH. Leukemia; 1993 Nov 21; 7(11):1858-64. PubMed ID: 8231253 [Abstract] [Full Text] [Related]
18. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice. Tang Y, Lu S, Gan X, Liu F, Zhang Y, Luo C, Pan Y, Hong L, Gan R. Oncol Rep; 2016 Feb 21; 35(2):905-11. PubMed ID: 26548532 [Abstract] [Full Text] [Related]
19. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB. Methods; 1997 Jan 21; 11(1):83-7. PubMed ID: 8990093 [Abstract] [Full Text] [Related]
20. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Eur J Immunol; 1990 Oct 21; 20(10):2293-9. PubMed ID: 2173662 [Abstract] [Full Text] [Related] Page: [Next] [New Search]